1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow RRMS: new trials by email Literature Review of RRMS trials Research Report on RRMS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis HP 13C pyruvate injection, MRI Scanner - Multiple Sclerosis, RRMS | Phase 2 | Recruiting | Ari Green | 40 | 2026-06-03 | 2026-06-08 |
| POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler AIN457, Placebo - Relapsing-remitting Multiple Sclerosis, RRMS | Phase 2 | Completed | Novartis Pharmaceuticals | 73 | 2009-12-01 | 2015-02-27 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Multiple Sclerosis (1)
secukinumab (1)
Ari Green (1) · Novartis Pharmaceuticals (1)
Czechia (1) · Russia (1) · Ukraine (1) · United States (1)
Ari Green, MD (1)
2009 (1), R01NS102156 (1)